Biologics Manufacturing and Nonclinical Services
Award Notice Posted
- Solicitation number
- 75N95022D00021
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Battelle Memorial Institute
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95022D00021 Federal IDV award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Notice details come from SAM.gov. Updated .
About this opportunity
This multiple-award IDIQ contract was awarded by the National Institutes of Health National Institute on Drug Abuse to Battelle Memorial Institute for $149.2 million. The contract provides for biologics manufacturing and nonclinical services to support new research and development programs, allowing for both fixed-price and cost-reimbursement task orders given the uncertainty in estimating costs for programs. The total contract value represents the maximum ordering amount across all task orders issued over the life of the contract.
Notice text
This is a multiple-award indefinite delivery, indefinite quantity (IDIQ) contract, which was awarded following a competitive solicitation. The total contract value represents the IDIQ maximum ordering value; all funds will be obligated at the task order level. This contract allows for the issuance of both fixed-price and cost-reimbursement type task orders. As the Statement of Work (SOW) entails research and develoment (R&D) services that will be supporting new programs, the Government cannot estimate the costs of performance with a reasonable or acceptable degree of accuracy. As a result, it was determined that limiting the contract to fixed-price task orders was not in the best interest of the Government.
Awarded contract 75N95022D00021 to BATTELLE MEMORIAL INSTITUTE for 149200000.00 on 2022-09-28.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity